These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9349593)

  • 1. A 973 valine to methionine mutation of the human insulin receptor: interaction with insulin-receptor substrate-1 and Shc in HEK 293 cells.
    Strack V; Bossenmaier B; Stoyanov B; Mushack J; Häring HU
    Diabetologia; 1997 Oct; 40(10):1135-40. PubMed ID: 9349593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation.
    Bossenmaier B; Strack V; Stoyanov B; Krützfeldt J; Beck A; Lehmann R; Kellerer M; Klein H; Ullrich A; Lammers R; Häring HU
    Diabetes; 2000 Jun; 49(6):889-95. PubMed ID: 10866039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
    van der Geer P; Wiley S; Pawson T
    Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of mutations at different serine residues on the tyrosine kinase activity of the insulin receptor.
    Strack V; Stoyanov B; Bossenmaier B; Mosthaf L; Kellerer M; Häring HU
    Biochem Biophys Res Commun; 1997 Oct; 239(1):235-9. PubMed ID: 9345301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events.
    Hamer I; Foti M; Emkey R; Cordier-Bussat M; Philippe J; De Meyts P; Maeder C; Kahn CR; Carpentier JL
    Diabetologia; 2002 May; 45(5):657-67. PubMed ID: 12107746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARgamma agonist restores normal cell signaling and differentiation.
    Sentinelli F; Filippi E; Cavallo MG; Romeo S; Fanelli M; Baroni MG
    J Endocrinol; 2006 Feb; 188(2):271-85. PubMed ID: 16461553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of insulin-stimulated tyrosine phosphorylation of IRS-1 and SHC by Wortmannin in intact cells.
    Li PM; Goldstein BJ
    Biochem Biophys Res Commun; 1996 Jun; 223(1):80-4. PubMed ID: 8660383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-independent and wortmannin-resistant targeting of IRS-3 to the plasma membrane via its pleckstrin homology domain mediates a different interaction with the insulin receptor from that of IRS-1.
    Kaburagi Y; Satoh S; Yamamoto-Honda R; Ito T; Ueki K; Akanuma Y; Sekihara H; Kimura S; Kadowaki T
    Diabetologia; 2001 Aug; 44(8):992-1004. PubMed ID: 11484076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin receptor substrate 4 supports insulin- and interleukin 4-stimulated proliferation of hematopoietic cells.
    Fantin VR; Keller SR; Lienhard GE; Wang LM
    Biochem Biophys Res Commun; 1999 Jul; 260(3):718-23. PubMed ID: 10403832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway.
    Zierath JR; Livingston JN; Thörne A; Bolinder J; Reynisdottir S; Lönnqvist F; Arner P
    Diabetologia; 1998 Nov; 41(11):1343-54. PubMed ID: 9833943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-induced serine phosphorylation of IRS-2 via ERK1/2 and mTOR: studies on the function of Ser675 and Ser907.
    Fritsche L; Neukamm SS; Lehmann R; Kremmer E; Hennige AM; Hunder-Gugel A; Schenk M; Häring HU; Schleicher ED; Weigert C
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E824-36. PubMed ID: 21098738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin signals to prenyltransferases via the Shc branch of intracellular signaling.
    Goalstone ML; Leitner JW; Berhanu P; Sharma PM; Olefsky JM; Draznin B
    J Biol Chem; 2001 Apr; 276(16):12805-12. PubMed ID: 11278505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long acting human insulin analog HOE 901: characteristics of insulin signalling in comparison to Asp(B10) and regular insulin.
    Berti L; Kellerer M; Bossenmaier B; Seffer E; Seipke G; Häring HU
    Horm Metab Res; 1998 Mar; 30(3):123-9. PubMed ID: 9566852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor subunit) proteins.
    Solow BT; Harada S; Goldstein BJ; Smith JA; White MF; Jarett L
    Mol Endocrinol; 1999 Oct; 13(10):1784-98. PubMed ID: 10517679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human insulin receptor juxtamembrane domain independent insulin signaling.
    Sattar AA; Berhanu C; Gebreselassie S; Berhanu P
    Cell Biol Int; 2007 Aug; 31(8):815-24. PubMed ID: 17344070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid induced insulin resistance in rat-1 fibroblasts overexpressing human insulin receptors: impaired insulin-stimulated mitogen-activated protein kinase activity.
    Usui I; Takata Y; Imamura T; Morioka H; Sasaoka T; Sawa T; Ishihara H; Ishiki M; Kobayashi M
    Diabetologia; 1997 Aug; 40(8):894-901. PubMed ID: 9267983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin signal transduction by a mutant human insulin receptor lacking the NPEY sequence. Evidence for an alternate mitogenic signaling pathway that is independent of Shc phosphorylation.
    Berhanu P; Anderson C; Hickman M; Ciaraldi TP
    J Biol Chem; 1997 Sep; 272(36):22884-90. PubMed ID: 9278451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two naturally occurring insulin receptor tyrosine kinase domain mutants provide evidence that phosphoinositide 3-kinase activation alone is not sufficient for the mediation of insulin's metabolic and mitogenic effects.
    Krook A; Whitehead JP; Dobson SP; Griffiths MR; Ouwens M; Baker C; Hayward AC; Sen SK; Maassen JA; Siddle K; Tavaré JM; O'Rahilly S
    J Biol Chem; 1997 Nov; 272(48):30208-14. PubMed ID: 9374504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms beta2 and theta.
    Strack V; Hennige AM; Krützfeldt J; Bossenmaier B; Klein HH; Kellerer M; Lammers R; Häring HU
    Diabetologia; 2000 Apr; 43(4):443-9. PubMed ID: 10819237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphorylation of phosphoinositide-dependent kinase 1 by the insulin receptor is necessary for insulin metabolic signaling.
    Fiory F; Alberobello AT; Miele C; Oriente F; Esposito I; Corbo V; Ruvo M; Tizzano B; Rasmussen TE; Gammeltoft S; Formisano P; Beguinot F
    Mol Cell Biol; 2005 Dec; 25(24):10803-14. PubMed ID: 16314505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.